reported that the chondroitin sulfate proteoglycan-4 (CSPG4)-redirected CAR-Ts administered into melanoma NOD scid gamma (NSG) mouse models, which were established using the human melanoma cell line WM115, exhibited enhanced tumoricidal activity after tumor ablation using photothermal therapy (96). Here, CSPG4 is linked to melanoma.